enzalutamide,talazoparib
astellas,pfizer
['talapro,2', 'crpc', 'talapro-2']
june 4th see talapro-2: phase 3 study of tala + enza versus pbo + enza as 1l treatment for patients with mcrpc harboring homologous recombination repair gene alterations with presenter karim fizazi, md #asco2023 
The official Twitter account for scientific news from the Prostate Cancer Foundation. Follow us at @PCFNews